| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 4, Issue 11 921-929, Copyright © 1993 by American Association of Cancer Research
ARTICLES |
BK Brott, A Alessandrini, DA Largaespada, NG Copeland, NA Jenkins, CM Crews and RL Erikson
Department of Cellular and Developmental Biology, Harvard University, Cambridge, Massachusetts 02138.
MEK1 is a dual specificity kinase that phosphorylates and activates the Erk/MAP kinases Erk-1 and Erk-2 by phosphorylating them on threonine and tyrosine. We report the cloning of a second MEK-like complementary DNA, Mek2, which predicts a protein of a molecular weight of 44,500. The MEK2 protein bears substantial sequence homology to MEK1, except at its amino terminus, and at a proline-rich region insert between the conserved kinase subdomains 9 and 10. MEK1 and MEK2 are shown to be encoded by different genes and are located on murine chromosomes 9 and 10, respectively. Northern analysis indicates that Mek2 is expressed at low levels in adult mouse brain and heart tissue, and at higher levels in other tissues examined. Low expression levels of Mek2 in brain tissue are in contrast to the high levels of Mek1 expressed in brain. Mek2 is expressed at high levels in neonatal brain, however. Recombinant MEK2 produced in bacteria phosphorylates a kinase-inactive Erk-1 on tyrosine and threonine, whereas a kinase-inactive mutant MEK2 does not. These findings suggest that MEK2 is a member of a multigene family.
This article has been cited by other articles:
![]() |
T. Senawong, J. Phuchareon, O. Ohara, F. McCormick, K. A. Rauen, and O. Tetsu Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: implications for therapeutic options Hum. Mol. Genet., February 1, 2008; 17(3): 419 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Bissonauth, S. Roy, M. Gravel, S. Guillemette, and J. Charron Requirement for Map2k1 (Mek1) in extra-embryonic ectoderm during placentogenesis Development, September 1, 2006; 133(17): 3429 - 3440. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, H. Feng, X.-Q. Huang, H. Xiang, Y.-W. Mao, J.-P. Liu, Q. Yan, W.-B. Liu, Y. Liu, M. Deng, et al. Human Telomerase Reverse Transcriptase Immortalizes Bovine Lens Epithelial Cells and Suppresses Differentiation through Regulation of the ERK Signaling Pathway J. Biol. Chem., June 17, 2005; 280(24): 22776 - 22787. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-F. Belanger, S. Roy, M. Tremblay, B. Brott, A.-M. Steff, W. Mourad, P. Hugo, R. Erikson, and J. Charron Mek2 Is Dispensable for Mouse Growth and Development Mol. Cell. Biol., July 15, 2003; 23(14): 4778 - 4787. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Klocker, P. Kermer, J. H. Weishaupt, M. Labes, R. Ankerhold, and M. Bahr Brain-Derived Neurotrophic Factor-Mediated Neuroprotection of Adult Rat Retinal Ganglion Cells In Vivo Does Not Exclusively Depend on Phosphatidyl-Inositol-3'-Kinase/Protein Kinase B Signaling J. Neurosci., September 15, 2000; 20(18): 6962 - 6967. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. WIDMANN, S. GIBSON, M. B. JARPE, and G. L. JOHNSON Mitogen-Activated Protein Kinase: Conservation of a Three-Kinase Module From Yeast to Human Physiol Rev, January 1, 1999; 79(1): 143 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Greulich and R. L. Erikson An Analysis of Mek1 Signaling in Cell Proliferation and Transformation J. Biol. Chem., May 22, 1998; 273(21): 13280 - 13288. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. K. Abe, K. T. Kahle, M. P. Saelzler, K. Orth, J. E. Dixon, and M. R. Rosner ERK7 Is an Autoactivated Member of the MAPK Family J. Biol. Chem., June 8, 2001; 276(24): 21272 - 21279. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |